Company Analysis Nephros, Inc.
1. Summary
Advantages
- Price (1.6 $) is less than fair price (2.1 $)
- The stock's return over the last year (-0.804%) is higher than the sector average (-9.06%).
- Current debt level 15.48% is below 100% and has decreased over 5 years from 21.55%.
Disadvantages
- Dividends (0%) are below the sector average (0.5431%).
- The company's current efficiency (ROE=-18.84%) is lower than the sector average (ROE=6.54%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Nephros, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 5.6% | 1.4% | -1.9% |
| 90 days | 23.4% | -9.9% | -17.1% |
| 1 year | -0.8% | -9.1% | 3.6% |
NEPH vs Sector: Nephros, Inc. has outperformed the "Healthcare" sector by 8.26% over the past year.
NEPH vs Market: Nephros, Inc. has underperformed the market marginally by -4.38% over the past year.
Stable price: NEPH is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: NEPH with weekly volatility of -0.0155% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (1.6 $) is lower than the fair price (2.1 $).
Price significantly below the fair price: The current price (1.6 $) is 31.3% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (64.63).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (93.32).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.84) is lower than that of the sector as a whole (4.52).
P/BV vs Market: The company's P/BV (3.84) is lower than that of the market as a whole (5.61).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.25) is lower than that of the sector as a whole (33.51).
P/S vs Market: The company's P/S indicator (2.25) is lower than that of the market as a whole (10.28).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-21.48) is lower than that of the sector as a whole (-19.11).
EV/Ebitda vs Market: The company's EV/Ebitda (-21.48) is lower than that of the market as a whole (19.31).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -13.3% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-13.3%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-26.26%).
5.4. ROE
ROE vs Sector: The company's ROE (-18.84%) is lower than that of the sector as a whole (6.54%).
ROE vs Market: The company's ROE (-18.84%) is lower than that of the market as a whole (5.31%).
5.5. ROA
ROA vs Sector: The company's ROA (-13.28%) is lower than that of the sector as a whole (-0.7601%).
ROA vs Market: The company's ROA (-13.28%) is lower than that of the market as a whole (6.12%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.94%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5431%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
